The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs

The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many…

The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,